Table 5. Correlations of HER-receptors and NRG1 with estrogen levels in normal tissue, tumour tissue and plasma.
|
|
Tumour |
|||||||
|---|---|---|---|---|---|---|---|---|
| EGFR/HER1 | HER2 | HER3 | HER4 | NRG1 | ||||
| Normal tissue | E1 | Totala | -0.458* | 0.084 | 0.367 | 0.276 | -0.315 | |
| ER+ | -0.498* | 0.276 | 0.423 | 0.370 | -0.236 | |||
| E2 | Total | -0.556** | 0.086 | 0.412 | 0.403 | -0.473* | ||
| ER+ | -0.494* | 0.187 | 0.327 | 0.291 | -0.437 | |||
| E1S | Total | 0.223 | 0.081 | 0.114 | 0.025 | 0.196 | ||
| ER+ | 0.211 | 0.049 | 0.147 | 0.004 | 0.158 | |||
| Tumour | E1 | Total | -0.148 | 0.136 | 0.200 | 0.238 | -0.106 | |
| ER+ | -0.343 | 0.257 | 0.354 | 0.463 | -0.214 | |||
| E2 | Total | -0.633** | 0.289 | 0.544** | 0.298 | -0.280 | ||
| ER+ | -0.676** | 0.164 | 0.261 | -0.115 | -0.542* | |||
| E1S | Total | 0.039 | 0.057 | 0.133 | 0.269 | 0.336 | ||
| ER+ | -0.029 | 0.015 | 0.220 | 0.394 | 0.320 | |||
| Plasma | E1 | Total | -0.509* | 0.464* | 0.336 | 0.187 | -0.331 | |
| ER+ | -0.529* | 0.245 | 0.255 | 0.047 | -0.475 | |||
| E2 | Total | -0.625** | 0.285 | 0.171 | 0.215 | -0.379 | ||
| ER+ | -0.647** | 0.140 | 0.206 | 0.194 | -0.436 | |||
| E1S | Total | -0.417 | 0.128 | 0.115 | 0.059 | -0.257 | ||
| ER+ | -0.321 | -0.069 | 0.034 | 0.017 | -0.228 | |||
a The total group of postmenopausal women and the subgroup of ER+ postmenopausal women
Spearman rank correlation (two tailed):
* P≤0.05
** P≤0.01